Cancer therapy with interferon
US4762705A · kind A · utility
20Cited by
0References
9Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Mar 29, 1984 |
| Grant date | Aug 9, 1988 |
| Priority date | — |
| Expiry date | Mar 29, 2004 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/21
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The effectiveness of interferon for treatment against cancer may be increased by first administering an agent for inhibiting tyrosinase. In this manner the tyrosinase which is known to be produced by malignancies, and which may cause inactivation of the interferon, will be substantially inactivated prior to the interferon administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.